22,335
edits
Changes
Jump to navigation
Jump to search
created
{{PhotoMissing}}
'''Francesc Xavier Bosch i José''', {{MD}}, {{MPH}}, ({{LifeData|birth=1947|birthplace=Barcelona|birthcountry=Spain}}), is a Spanish physician and epidemiologist.<ref>{{REFweb
|url=https://www.enciclopedia.cat/gran-enciclopedia-catalana/francesc-xavier-bosch-i-jose
|title=Francesc Xavier Bosch José (Q56376448)
|publisher=Enciclopèdia.cat
|accessdate=2022-08-04
}}</ref>
== Profile ==
F. Xavier Bosch is senior consultant to the Cancer Epidemiology Research Program (CERP) at the Catalan Institute of Oncology (ICO) in Barcelona, Spain. He also serves as Chief of International Affairs at ICO and is the Executive Director of the ICO/IARC Information Centre on [[HPV]] and [[Cervical Cancer]] (www.who.int/hpvcentre). Dr. Bosch is the editor in chief of the journal Papillomavirus Research (PVR) and the editor of the international newsletter [[HPV]] Today (www.hpvtoday.com), served as guest editor for the [[HPV]] MONOGRAPH series (Vaccine, Elsevier) and is the organizer and current Director of an e-learning effort in oncology and notably on e-courses on [[cervical cancer]] prevention (www.eoncologia.net). He served as epidemiologist at the International Agency for Research on Cancer (Lyon, France 1982-1993) and as visiting scientist at the National Cancer Institute (Washington, USA 2002).<ref name=ipvsoc>{{REFweb
|url=https://ipvsoc.org/member/xavier-bosch/
|title=Bosch, F. Xavier
|publisher=International Papillomavirus Society
|accessdate=2022-08-04
}}</ref>
Dr. Bosch has conducted epidemiological research on cancers linked to infectious agents notably on cancer of the liver, the cervix, the genital tract and of the oral cavity and oropharynx. Dr Bosch was at the origin of the IARC program of epidemiological studies that demonstrated causality in the [[HPV]] and invasive [[cervical cancer]] relationship, established the role of the environmental co-factors for carcinogenesis among [[HPV]] positive women, and described the international variation of [[HPV]] types in [[cervical cancer]]. Some of these studies have played a catalytic role for the initiation of the first vaccine trials for HBV and [[HPV]] and for the evaluation of [[HPV]] tests as screening tools. Current interest reside in dissemination of scientific information of clinical relevance and in studies that integrate [[HPV]] vaccination and screening in environments with limited resources.<ref name=ipvsoc/>
{{PUB}}
Dr. Bosch’s publications in relation to [[HPV]] and [[cervical cancer]] amount to over 420 original publications, over 25 monograph books and major reviews and over 700 scientific communications at medical meetings.<ref name=ipvsoc/>
His name is commonly abbreviated as '''F. Xavier Bosch''' or '''Bosch FX''' in publications.
It is noteworthy that his CV at the Cancer Epidemiology Research Programme (PREC) at the Catalan Institute of Oncology (ICO) doesn't mention [[circumcision]] at all.<ref>{{REFweb
|url=https://icoepi.net/staff/f-xavier-bosch/
|title=Francesc Xavier Bosch Jose, e-oncologia Director and scientific advisor
|accessdate=2022-08-04
}}</ref> Nevertheless, he co-authored several journal articles which link [[circumcision]] to protection from cancer, among other things as co-author of the [[circumfetishist]] [[Brian J. Morris]], e.g.:
* {{REFjournal
|last=Bosch
|init=FX
|author-link=F. Xavier Bosch
|last2=Castellsagué
|init2=X
|author2-link=Xavier Castellsagué
|last3=Munoz
|init3=N
|etal=yes
|title=Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain
|journal=J Natl Cancer Inst
|date=1996
|volume=88
|pages=1060-7
}}
* {{REFjournal
|last=Munoz
|init=N
|last2=Castellsagué
|init2=X
|author2-link=Xavier Castellsagué
|last3=Bosch
|init3=FX
|author3-link=F. Xavier Bosch
|etal=yes
|title=Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease
|journal=J Natl Cancer Inst
|date=1996
|volume=88
|pages=1068-75
}}
* {{REFjournal
|title=Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
|url=https://www.nejm.org/doi/full/10.1056/nejmoa011688
|last=Castellsagué
|first=Xavier
|init=X
|author-link=Xavier Castellsagué
|last2=Bosch
|first2=F. Xavier
|init2=FX
|author2-link=F. Xavier Bosch
|last3=Muñoz
|first3=Nubia
|init3=N
|last4=Meijer
|first4=Chris J.L.M.
|init4=CJLM
|last5=Shah
|first5=Keerti V.
|init5=KV
|last6=de Sanjosé
|first6=Silvia
|init6=S
|last7=Eluf-Neto
|first7=José
|init7=J
|last8=Ngelangel
|first8=Corazon A.
|init8=CA
|last9=Chichareon
|first9=Saibua
|init9=S
|etal=yes
|last10=Smith
|first10=Jennifer S.
|init10=JS
|last11=Herrero
|first11=Rolando
|init11=R
|last12=Moreno
|first12=Victor
|init12=V
|last13=Franceschi
|firat14=Silvia
|init14=S
|journal=N Engl J Med
|volume=346
|pages=1105-12
|DOI=10.1056/NEJMoa011688
|date=2002-04-11
|accessdate=2022-08-04
}}
* {{REFjournal
|journal=J Fam Plann Reprod Health Care
|date=2009-01
|accessdate=2022-08-04
|volume=35
|issue=1
|pages=5-7
|title=Male circumcision, human papillomavirus and cervical cancer: from evidence to intervention
|url=https://pubmed.ncbi.nlm.nih.gov/19126309/
|last=Bosch
|first=F. Xavier
|init=FX
|author-link=F. Xavier Bosch
|last2=Albero
|first2=Ginesa
|init2=G
|last3=Castellsagué
|first3=Xavier
|init3=X
|author3-link=Xavier Castellsagué
|pubmedID=19126309
|DOI=10.1783/147118909787072270
}}
* {{Morris2011}}
* {{REFjournal
|title=Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study
|url=https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-13-18
|last=Albero
|first=Ginesa
|init=G
|last2=Villa
|first2=Luisa L.
|init2=LL
|last3=Lazcano-Ponce
|first3=Eduardo
|init3=E
|last4=Fulp
|first4=William
|init4=W
|last5=Papenfuyy
|first5=Mary R.
|init5=MR
|last6=Nyitray
|first6=Alan G.
|init6=AG
|last7=Lu
|first7=Beibei
|init7=B
|last8=Castellsagué
|first8=Xavier
|init8=X
|author8-link=Xavier Castellsagué
|last9=Abrahamsen
|first9=Martha
|init9=M
|etal=yes
|last10=Smith
|first10=Danélle
|init10=D
|last11=Bosch
|first11=F. Xavier
|init11=FX
|author11-link=F. Xaviere Bosch
|last12=Salmerón
|first12=Jorge
|init12=J
|last13=Quiterio
|first13=Manuel
|init13=M
|last14=Giuliano
|first14=Anna R.
|init14=AR
|journal=BMC Infectious Diseases
|volume=13
|issue=18
|date=2013-01-17
|accessdate=2022-08-04
}}
* {{REFjournal
|title=Male circumcision and the incidence and clearance of genital human papillomavirus (HPV) infection in men: the HPV Infection in men (HIM) cohort study
|url=https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-14-75
|last=Albero
|first=Ginesa
|init=G
|last2=Castellsagué
|first2=Xavier
|init2=X
|author2-link=Xavier Castellsagué
|last3=Lin
|first3=Hui-Yi
|init3=HY
|last4=Fulp
|first4=William
|init4=W
|last5=Villa
|first5=Luisa L.
|init5=LL
|last6=Lazcano-Ponce
|first6=Eduardo
|init6=E
|last7=Papenfuss
|first7=Mary
|init7=M
|last8=Abrahamsen
|first8=Martha
|init8=M
|last9=Salmerón
|first9=Jorge
|init9=J
|etal=yes
|last10=Quiterio
|first10=Manuel
|init10=M
|last11=Nyitray
|first11=Alan G.
|init11=AG
|last12=Lu
|first12=Beibei
|init12=B
|last13=Bosch
|first13=F. Xavier
|init13=FX
|last14=Giuliano
|first14=Anna R.
|init14=AR
|journal=BMC Infectious Diseases
|volume=14
|issue=75
|date=2014-02-10
|accessdate=2022-08-04
}}
{{LINKS}}
* {{REFweb
|url=https://typeset.io/authors/f-xavier-bosch-26oqxkjedp
|title=F. Xavier Bosch
|publisher=SciSpace
|accessdate=2022-08-04
}}
{{ABBR}}
{{REF}}
{{DEFAULTSORT:Bosch José, Francesc Xavier}}
[[Category:Person]]
[[Category:Male]]
[[Category:Promoter]]
[[Category:Researcher]]
[[Category:Spain]]
'''Francesc Xavier Bosch i José''', {{MD}}, {{MPH}}, ({{LifeData|birth=1947|birthplace=Barcelona|birthcountry=Spain}}), is a Spanish physician and epidemiologist.<ref>{{REFweb
|url=https://www.enciclopedia.cat/gran-enciclopedia-catalana/francesc-xavier-bosch-i-jose
|title=Francesc Xavier Bosch José (Q56376448)
|publisher=Enciclopèdia.cat
|accessdate=2022-08-04
}}</ref>
== Profile ==
F. Xavier Bosch is senior consultant to the Cancer Epidemiology Research Program (CERP) at the Catalan Institute of Oncology (ICO) in Barcelona, Spain. He also serves as Chief of International Affairs at ICO and is the Executive Director of the ICO/IARC Information Centre on [[HPV]] and [[Cervical Cancer]] (www.who.int/hpvcentre). Dr. Bosch is the editor in chief of the journal Papillomavirus Research (PVR) and the editor of the international newsletter [[HPV]] Today (www.hpvtoday.com), served as guest editor for the [[HPV]] MONOGRAPH series (Vaccine, Elsevier) and is the organizer and current Director of an e-learning effort in oncology and notably on e-courses on [[cervical cancer]] prevention (www.eoncologia.net). He served as epidemiologist at the International Agency for Research on Cancer (Lyon, France 1982-1993) and as visiting scientist at the National Cancer Institute (Washington, USA 2002).<ref name=ipvsoc>{{REFweb
|url=https://ipvsoc.org/member/xavier-bosch/
|title=Bosch, F. Xavier
|publisher=International Papillomavirus Society
|accessdate=2022-08-04
}}</ref>
Dr. Bosch has conducted epidemiological research on cancers linked to infectious agents notably on cancer of the liver, the cervix, the genital tract and of the oral cavity and oropharynx. Dr Bosch was at the origin of the IARC program of epidemiological studies that demonstrated causality in the [[HPV]] and invasive [[cervical cancer]] relationship, established the role of the environmental co-factors for carcinogenesis among [[HPV]] positive women, and described the international variation of [[HPV]] types in [[cervical cancer]]. Some of these studies have played a catalytic role for the initiation of the first vaccine trials for HBV and [[HPV]] and for the evaluation of [[HPV]] tests as screening tools. Current interest reside in dissemination of scientific information of clinical relevance and in studies that integrate [[HPV]] vaccination and screening in environments with limited resources.<ref name=ipvsoc/>
{{PUB}}
Dr. Bosch’s publications in relation to [[HPV]] and [[cervical cancer]] amount to over 420 original publications, over 25 monograph books and major reviews and over 700 scientific communications at medical meetings.<ref name=ipvsoc/>
His name is commonly abbreviated as '''F. Xavier Bosch''' or '''Bosch FX''' in publications.
It is noteworthy that his CV at the Cancer Epidemiology Research Programme (PREC) at the Catalan Institute of Oncology (ICO) doesn't mention [[circumcision]] at all.<ref>{{REFweb
|url=https://icoepi.net/staff/f-xavier-bosch/
|title=Francesc Xavier Bosch Jose, e-oncologia Director and scientific advisor
|accessdate=2022-08-04
}}</ref> Nevertheless, he co-authored several journal articles which link [[circumcision]] to protection from cancer, among other things as co-author of the [[circumfetishist]] [[Brian J. Morris]], e.g.:
* {{REFjournal
|last=Bosch
|init=FX
|author-link=F. Xavier Bosch
|last2=Castellsagué
|init2=X
|author2-link=Xavier Castellsagué
|last3=Munoz
|init3=N
|etal=yes
|title=Male sexual behavior and human papillomavirus DNA: key risk factors for cervical cancer in Spain
|journal=J Natl Cancer Inst
|date=1996
|volume=88
|pages=1060-7
}}
* {{REFjournal
|last=Munoz
|init=N
|last2=Castellsagué
|init2=X
|author2-link=Xavier Castellsagué
|last3=Bosch
|init3=FX
|author3-link=F. Xavier Bosch
|etal=yes
|title=Difficulty in elucidating the male role in cervical cancer in Colombia, a high-risk area for the disease
|journal=J Natl Cancer Inst
|date=1996
|volume=88
|pages=1068-75
}}
* {{REFjournal
|title=Male Circumcision, Penile Human Papillomavirus Infection, and Cervical Cancer in Female Partners
|url=https://www.nejm.org/doi/full/10.1056/nejmoa011688
|last=Castellsagué
|first=Xavier
|init=X
|author-link=Xavier Castellsagué
|last2=Bosch
|first2=F. Xavier
|init2=FX
|author2-link=F. Xavier Bosch
|last3=Muñoz
|first3=Nubia
|init3=N
|last4=Meijer
|first4=Chris J.L.M.
|init4=CJLM
|last5=Shah
|first5=Keerti V.
|init5=KV
|last6=de Sanjosé
|first6=Silvia
|init6=S
|last7=Eluf-Neto
|first7=José
|init7=J
|last8=Ngelangel
|first8=Corazon A.
|init8=CA
|last9=Chichareon
|first9=Saibua
|init9=S
|etal=yes
|last10=Smith
|first10=Jennifer S.
|init10=JS
|last11=Herrero
|first11=Rolando
|init11=R
|last12=Moreno
|first12=Victor
|init12=V
|last13=Franceschi
|firat14=Silvia
|init14=S
|journal=N Engl J Med
|volume=346
|pages=1105-12
|DOI=10.1056/NEJMoa011688
|date=2002-04-11
|accessdate=2022-08-04
}}
* {{REFjournal
|journal=J Fam Plann Reprod Health Care
|date=2009-01
|accessdate=2022-08-04
|volume=35
|issue=1
|pages=5-7
|title=Male circumcision, human papillomavirus and cervical cancer: from evidence to intervention
|url=https://pubmed.ncbi.nlm.nih.gov/19126309/
|last=Bosch
|first=F. Xavier
|init=FX
|author-link=F. Xavier Bosch
|last2=Albero
|first2=Ginesa
|init2=G
|last3=Castellsagué
|first3=Xavier
|init3=X
|author3-link=Xavier Castellsagué
|pubmedID=19126309
|DOI=10.1783/147118909787072270
}}
* {{Morris2011}}
* {{REFjournal
|title=Male circumcision and prevalence of genital human papillomavirus infection in men: a multinational study
|url=https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-13-18
|last=Albero
|first=Ginesa
|init=G
|last2=Villa
|first2=Luisa L.
|init2=LL
|last3=Lazcano-Ponce
|first3=Eduardo
|init3=E
|last4=Fulp
|first4=William
|init4=W
|last5=Papenfuyy
|first5=Mary R.
|init5=MR
|last6=Nyitray
|first6=Alan G.
|init6=AG
|last7=Lu
|first7=Beibei
|init7=B
|last8=Castellsagué
|first8=Xavier
|init8=X
|author8-link=Xavier Castellsagué
|last9=Abrahamsen
|first9=Martha
|init9=M
|etal=yes
|last10=Smith
|first10=Danélle
|init10=D
|last11=Bosch
|first11=F. Xavier
|init11=FX
|author11-link=F. Xaviere Bosch
|last12=Salmerón
|first12=Jorge
|init12=J
|last13=Quiterio
|first13=Manuel
|init13=M
|last14=Giuliano
|first14=Anna R.
|init14=AR
|journal=BMC Infectious Diseases
|volume=13
|issue=18
|date=2013-01-17
|accessdate=2022-08-04
}}
* {{REFjournal
|title=Male circumcision and the incidence and clearance of genital human papillomavirus (HPV) infection in men: the HPV Infection in men (HIM) cohort study
|url=https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-14-75
|last=Albero
|first=Ginesa
|init=G
|last2=Castellsagué
|first2=Xavier
|init2=X
|author2-link=Xavier Castellsagué
|last3=Lin
|first3=Hui-Yi
|init3=HY
|last4=Fulp
|first4=William
|init4=W
|last5=Villa
|first5=Luisa L.
|init5=LL
|last6=Lazcano-Ponce
|first6=Eduardo
|init6=E
|last7=Papenfuss
|first7=Mary
|init7=M
|last8=Abrahamsen
|first8=Martha
|init8=M
|last9=Salmerón
|first9=Jorge
|init9=J
|etal=yes
|last10=Quiterio
|first10=Manuel
|init10=M
|last11=Nyitray
|first11=Alan G.
|init11=AG
|last12=Lu
|first12=Beibei
|init12=B
|last13=Bosch
|first13=F. Xavier
|init13=FX
|last14=Giuliano
|first14=Anna R.
|init14=AR
|journal=BMC Infectious Diseases
|volume=14
|issue=75
|date=2014-02-10
|accessdate=2022-08-04
}}
{{LINKS}}
* {{REFweb
|url=https://typeset.io/authors/f-xavier-bosch-26oqxkjedp
|title=F. Xavier Bosch
|publisher=SciSpace
|accessdate=2022-08-04
}}
{{ABBR}}
{{REF}}
{{DEFAULTSORT:Bosch José, Francesc Xavier}}
[[Category:Person]]
[[Category:Male]]
[[Category:Promoter]]
[[Category:Researcher]]
[[Category:Spain]]